Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation

Blood Advances(2023)10.1182/bloodadvances.2022009112Source: DataRank Database

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation is a research paper published in Blood Advances (2023). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.35)OA: goldTopics (52)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Hu Xie ORCID,Danniel Zamora ORCID,Mary E.D. Flowers ORCID,Geoffrey R. Hill ORCID,Marco Mielcarek ORCID

Live enrichment

PubMed:36595478 PMC:PMC10139935 OpenAlex:https://openalex.org/W4313453980

NIAID NIH HHS

Grant: K23 AI163343

National Institutes of Health

Grant: 7K23AI163343-06

Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis

FWCI

4.35

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://ashpublications.org/bloodadvances/article-pdf/7/8/1394/2045899/blooda_adv-2022-009112-main.pdf

publisherhttps://ashpublications.org/bloodadvances/article-pdf/7/8/1394/2045899/blooda_adv-2022-009112-main.pdf

journalhttps://doi.org/10.1182/bloodadvances.2022009112

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36595478

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10139935

Fields of Study

Cytomegalovirus and herpesvirus researchHematopoietic Stem Cell TransplantationPolyomavirus and related diseases0301 basic medicine0303 health sciences03 medical and health sciencesHumansPeripheral Blood Stem Cell TransplantationRetrospective StudiesImmunosuppressive AgentsGraft vs Host DiseaseMycophenolic AcidMethotrexateCytomegalovirus Infections

MeSH Terms

Cytomegalovirus InfectionsGraft vs Host DiseaseHumansImmunosuppressive AgentsMethotrexateMycophenolic AcidRetrospective StudiesPeripheral Blood Stem Cell Transplantation

Keywords

MedicineImmunologyTransplantationMethotrexateGraft-versus-host diseaseViral loadHematopoietic stem cell transplantationCalcineurinTacrolimusInternal medicineHuman leukocyte antigenCytomegalovirusCyclophosphamideGastroenterologyHerpesviridaeViral diseaseChemotherapyAntigenVirusPeripheral Blood Stem Cell TransplantationGraft vs Host Disease32 Biomedical and Clinical SciencesHematologyMycophenolic Acid3204 ImmunologyCytomegalovirus InfectionsHumans3201 Cardiovascular medicine and haematologyImmunosuppressive AgentsRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity

10.6084/m9.figshare.26157253.v1figshare

Additional file 1 of Characterization of recurrent cytomegalovirus reactivations post allogenic stem cell transplantation in a population with high seropositivity

10.6084/m9.figshare.26157253figshare